Role of alpha1-adrenergic receptor antibodies in Alzheimer's disease

Tools

Item Type:	Article
Title:	Role of alpha1-adrenergic receptor antibodies in Alzheimer's disease
Creators Name:	Karczewski, P., Hempel, P. and Bimmler, M.
Abstract:	Agonistic autoantibodies (agAAB) for alpha-1 adrenoceptor were found in approx. 50% of patients with Alzheimer's disease. These antibodies activate the receptor and trigger the signal cascades similarly to how natural agonists do. The agAAB bond to the receptor is persistent and prolonged. This results in a non-physiological elevation of intracellular calcium. An animal model has shown that agAAB causes macrovascular and microvascular impairment in the vessels of the brain. Reduction in blood flow and the density of intact vessels was significantly demonstrated. The agAAB was removed through immunoadsorption in a small cohort of patients with Alzheimer's disease. Subsequent follow-up observations over 12-18 months noted stabilization of cognition levels.
Keywords:	Dementia, Agonistic Autoantibodies, Immunoadsorption, Review, Animals
Source:	Frontiers in Bioscience
ISSN:	1093-9946
Publisher:	Frontiers in Bioscience
Volume:	23
Page Range:	2082-2089
Date:	1 June 2018
Official Publication:	https://www.bioscience.org/2018/v23/af/4691/fulltext.htm
PubMed:	View item in PubMed

Repository Staff Only: item control page